Vitamin B12 is key for making red blood cells, nerve function, and DNA
Week 2 Finding your rhythm Youll start your medication with guidance from your care team, and begin tracking how your body responds
Instead, the arrival of oral GLP-1s is likely to attract needle-hesitant patients, effectively expanding the total addressable market (TAM) rather than displacing the existing one
#WeAreEvernorth #NationalPharmacyMonth Biosimilars can do more than bring access and affordability to the specialty medication market
It is interesting to note that CP17, which was originally designed to target the lipid-binding pocket within VP1, binds very specifically at a completely separate site and shows no evidence of binding within the targeted pocket
David: Yeah, so that's four middlemen